#1ad resultados da pesquisa
Tiger ROARS to @CoachStikes @FCHSTIGERSPORTS #1AD #4AAAA @fcboe 🖤💛🐅
Honored to represent region 4-AAAA as @GADACOACHES region AD of the year! Thankful for admin team at @FCHSTigers that supports me & our coaches as well as great region ADs that make this job fun! Most important is a great family that loves & supports me-thanks Brittany & kids!
We've just posted the following update on our investor hub: BioShares covers East to West cellular therapy launch with Speculative Buy - Class B rating Check out the full update and join in with the conversation at: investorhub.adalta.com.au/activity-updat… #1AD
AdAlta's (ASX:1AD) CEO and Managing Director Tim Oldham sat down with @Stockhead’s Ashtyn Hiron. Tune in to hear Tim discuss the exciting new MoU with SYNBV for cancer immunotherapy and what it means for the company's future | investorhub.adalta.com.au/activity-updat… #1AD
AdAlta's (ASX:1AD) CEO and MD Tim Oldham joined SYNthesis BioVentures's MD Professor Andrew Wilks on last Thursday's webinar to discuss the exciting partnership between SYNthesis and Adalta | investorhub.adalta.com.au/activity-updat… #1AD #Webinar
Join AdAlta’s CEO and MD, Dr Tim Oldham to discuss the recently announced collaboration with Shanghai Cell Therapy Group to develop a ground breaking CAR-T cell therapy for global markets. Webinar: Thu, 15 Jan 2026 1:00–1:40pm AEST Register: investorhub.adalta.com.au/webinars/mepmB… #1AD
#biotech #1AD #1ADOA ~$3M EV here and getting a bit of attention @PeakAsset1
AdAlta (ASX:1AD) - Webinar Presentation @AdAlta1AD #1AD youtu.be/W0hJNxpYLp0?si…
"AdAlta (ASX:1AD) has raised $1.9m through the exercise of options as it advances strategic partnerships during H2 CY24" - @StockheadAU reports | Read more: stockhead.com.au/health/adalta-… #1AD
We've just released the following announcement: AdCella expands clinical advisory board Check out the full announcement and join in with the conversation at: investorhub.adalta.com.au/announcements/… #1AD
AdAlta (ASX:1AD) is pleased to announce CEO and MD, Tim Oldham will host an investor update webinar to discuss recently announced significant growth funding from New Life Sciences Capital LLC and Meurs Group. Register here: us02web.zoom.us/webinar/regist… #1AD #ASX
#AN1 006 WIPED💥 Looks like this is ready for a run, #AN1 has a much better register than #1AD so look out folks... #ASX #Biotech
$1AD AdAlta doses volunteers in Phase 1 extension study of AD-214, with promising safety results tinyurl.com/yuatk4n7 @AdAltaCEO #1AD #ASX #ASXNews
$1AD AdAlta to present lead product AD-214 at MPGPCR 2023 pharmacology conference tinyurl.com/yol23g4l @AdAltaCEO #1AD #ASX #ASXNews
$1AD AdAlta clinical dose simulations of AD-214 support target intravenous dose regime tinyurl.com/26aw8dh4 @AdAltaCEO #1AD #ASX #ASXNews
🇦🇺 What a ripper of a day today... $RLF with the pop as we get nearer to the next quarterly. $COV with a nice bounce from the post cap raise consolidation. Big week of buying, #1AD nice accumulating around 0.006 #AI1 the selling slowed down, will buy more next week. #asx
$1AD 62 Capital getting behind them 0.3c Every stock they’ve touched recently has been a multi bagger Let’s go
Time to check $$$ balances of my #ASX stocks, All are reasonably CASHED UP except $EMA ($0.5M) #1AD -$2.7M $ALR -$12.1M #AN1 -$2.2M #BM8 -$4.4M $BMM -$2.7M $CRR -$2.7M $DAL -$1.3M?? $DVL -$4.9M #I88 -$11.9M #LU7 -$2.0M $NVU -$9.3M $PMM -$1.1M $SIS -$2.9M $SKN -$1.7M $VMM -$15.1M
Last Day of 2025 All the accumulation done✅ New additions👇 $SKN #1AD $SIS #AN1 Still Holding👇 $NVU - #semiconductors #AI #Drones #I88 - #Uranium $DVL - #Robotics #RRAM #sensortech $CRR - #Lithium #BatteryTech #BM8 - #germanium #Silver $BMM - #REE #ProcessingTech $VMM
AdAlta's (ASX:1AD) CEO and MD, Tim Oldham will host a webinar to discuss AdAlta’s new collaboration with SYNthesis BioVentures under a Memorandum of Understanding announced on Monday 8 April 2024 and general business progress | Register us02web.zoom.us/webinar/regist… #1AD #Webinar
🔒AdAlta Limited (ASX: 1AD) secures a Canadian patent for AD-214, completing global protection for the anti-fibrotic product. 📌Expiry: January 2036 🌍Protected in key markets 🧬Targets IPF & kidney fibrosis kapitales.com.au/news/latest/ad… #ASX #1AD #Biotech #IPF #Fibrosis
$1AD AdAlta secures Canadian patent, completing global protection for AD-214 fibrosis drug tinyurl.com/23spy6qq @AdAltaCEO #1AD #ASX #ASXNews
#1AD Canadian patent protecting AD-214 granted Grant completes composition of matter protection for AD-214 in major markets The Company developer of next generation cell and protein therapeutic products is pleased to announce that it has been granted a new composition of
We've just released the following announcement: Fadi Diab to join AdAlta Board Check out the full announcement and join in with the conversation at: investorhub.adalta.com.au/announcements/… #1AD
AdAlta's (ASX:1AD) CEO and Managing Director Tim Oldham sat down with @Stockhead’s Ashtyn Hiron. Tune in to hear Tim discuss the exciting new MoU with SYNBV for cancer immunotherapy and what it means for the company's future | investorhub.adalta.com.au/activity-updat… #1AD
$1AD #1AD a little sleeper that’s come on my radar of the back of some volume yesterday, a few presentations this week pitching to the asia market. Taken a starter parcel with #bios going silly of late Could get legs real quick if interest grows or any news!! DYOR
Join AdAlta’s CEO and MD, Dr Tim Oldham to discuss the recently announced collaboration with Shanghai Cell Therapy Group to develop a ground breaking CAR-T cell therapy for global markets. Webinar: Thu, 15 Jan 2026 1:00–1:40pm AEST Register: investorhub.adalta.com.au/webinars/mepmB… #1AD
#PGA Content #Alert @ATTProam We're back! Full Field! ⛳️⛳️⛳️ #1AD #Championship #Golf #DFS Course Preview, #Showdown Strategy & #Sleepers DK Contest: 💰: draftkings.com/draft/contest/… ⛳️⛳️⛳️ @FantasyNational @DraftKings Preview! 📺: youtube.com/watch?v=Y6OdNw…
@AdAlta1AD is pleased to invite shareholders/potential investors to a series of upcoming briefings at @AustSharesAssoc Investor Summit 2023 and in person. #1AD CEO & MD Dr @TimOldhamAU will discuss #AD214 and partnering. Register: tinyurl.com/muuce4bx $1AD #IPF
AdAlta (ASX:1AD) will present at @sharecafetweets' Hidden Gems Webinar with a focus on the successful AD-214 Phase I Extension Study and what it means for Phase II and partner opportunities | Register: us02web.zoom.us/webinar/regist… #1AD #Webinar #FDA
Join AdAlta's (ASX:1AD) CEO and Managing Director, Tim Oldham as he presents imapac's 2nd Australia Biologics Festival on 21 February 2024 | imapac.com/events/austral… @imapac #1AD #Biologics
AdAlta's (ASX:1AD) CEO and MD, Tim Oldham will host a webinar to discuss AdAlta’s new collaboration with SYNthesis BioVentures under a Memorandum of Understanding announced on Monday 8 April 2024 and general business progress | Register us02web.zoom.us/webinar/regist… #1AD #Webinar
Its raining #offers in #Akashavani @cbsairhyd now pay for #1ad and get #2ads #free plus get #Discount10% exclusive offer for #VividhbharatiFM102.8 #FmRainbow101.9 #HURRY offer valid for a limited period #contactus on ☎️ 08332059580 [email protected] #SalesCentreHyderabad
Content #Alert @RoyalTroonGC @TheOpen Champion golfer of the year! ⛳️⛳️⛳️ #1AD #Championship #Golf #RNA #DFS ⛳️⛳️⛳️ @FantasyNational @DraftKings Preview! 📺: youtube.com/watch?v=X4lsU8…
"AdAlta (ASX:1AD) has raised $1.9m through the exercise of options as it advances strategic partnerships during H2 CY24" - @StockheadAU reports | Read more: stockhead.com.au/health/adalta-… #1AD
AdAlta raises $1.9m of new equity from the exercise of its listed 1ADOA options. The funds will help AdAlta advance strategic partnerships & deliver enhanced financing flexibility | Read ASX announcement: cdn-api.markitdigital.com/apiman-gateway… #1AD
We've just released the following announcement: AdCella expands clinical advisory board Check out the full announcement and join in with the conversation at: investorhub.adalta.com.au/announcements/… #1AD
#PGATour @TheRSMClassic ⛳️⛳️⛳️ #1AD #Championship #Golf #RNA #DFS cutsweats.com #DFS #PGA 2 course's to look at! ⛳️⛳️⛳️ @FantasyNational @DraftKings Preview! 📺: youtube.com/watch?v=3xelib…
#PGA Content #Alert @Cognizant Classic We're back! Full Field! ⛳️⛳️⛳️ #1AD #Championship #Golf #DFS Course Preview, #Showdown Strategy & #Sleepers Already 30 in let's get more! DK Contest: draftkings.com/draft/contest/… ⛳️⛳️⛳️ @FantasyNational @DraftKings Preview! 📺:
🚨 #1AD on a serious run — don’t miss the INVESTOR WEBINAR | THIS THURSDAY 🚨 🧬 Armoured CAR-T (BZDS1901) 🌏 East ➡️ West global strategy 🎤 CEO update + live Q&A 🕐 15 Jan | 1pm AEST 🔗 Register 👇 investorhub.adalta.com.au/webinars/mepmB Solid tumour CAR-T opportunities don’t come often 👀
AdAlta (ASX:1AD) has announced the formation of a Clinical Advisory Board and the appointment of an additional adviser for its lead asset AD-214, which is being developed to treat Idiopathic Pulmonary Fibrosis | ASX announcement: investorhub.adalta.com.au/announcements/… #1AD
AdAlta (ASX:1AD) was pleased to have CEO and Managing Director, Tim Oldham discuss the significant growth funding announced on Monday 29 April 2024 and answer investor questions | Watch here: investorhub.adalta.com.au/activity-updat… #1AD #Webinar #Funding #ASX
Something went wrong.
Something went wrong.
United States Trends
- 1. TACO N/A
- 2. Witch N/A
- 3. Jaxon Smith N/A
- 4. Leonid Radvinsky N/A
- 5. #MondayMotivation N/A
- 6. NovaRed Mining Inc. N/A
- 7. Good Monday N/A
- 8. Witkoff N/A
- 9. LaGuardia N/A
- 10. Fournette N/A
- 11. Puka N/A
- 12. #NationalPuppyDay N/A
- 13. #BuschKeeper N/A
- 14. LaGuardia Airport N/A
- 15. Air Canada N/A
- 16. Strider N/A
- 17. U.S. and Iran N/A
- 18. Alan Huss N/A
- 19. #NoHayAmnistíaParaCriminales N/A
- 20. Reacher N/A